You searched for "oedema"
Hyper reflective foci (HRF) on OCT in diabetic retinopathy
1 April 2015
| Saruban Pasu
|
EYE - Vitreo-Retinal
This study investigated the presence of hyper reflective foci (HRF) in asymptomatic patients affected by type 1 or type 2 diabetes, separately, without clinically significant diabetic macular oedema and visual impairment. In total 71 eyes with non-proliferative diabetic retinopathy were...
Glaucoma management after congenital cataract
The purpose of this study was to retrospectively explore the results of surgical intervention for glaucoma after congenital cataract surgery in Egypt. The study included 41 eyes of 32 children with glaucoma after cataract surgery – 57 procedures; 90% having...Ground control to optic nerve – the space oddity to be studied
1 August 2025
| Zhihang Cheng
|
EYE - Neuro-ophthalmology
The authors explore the clinical entity that is known as Spaceflight Associated Neuro-ocular Syndrome (SANS). Its clinical characteristics include optic disc oedema, hyperopic refractive shifts, globe flattening, and chorioretinal folds, may pose a health risk for future space exploration. Understanding...
Mini DMEK for acute hydrops
This is a retrospective analysis of three patients who underwent mini DMEK for massive corneal hydrops in acute keratoconus. DMEK graft was trephined or trimmed according to the size and the shape of the gap in the patient’s Descemet membrane...Retinal ischaemia on OCTA and diabetic retinopathy grade
1 April 2020
| Saruban Pasu
|
EYE - Vitreo-Retinal
The authors quite rightly point out that quantification of retinal ischaemia has the potential to serve as a biomarker for diabetic retinopathy disease progression. They set out to investigate the relationship between area of ischaemia on a swept source OCTA...
Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?
1 February 2017
| Usha Chakravarthy (Prof)
|
EYE - Vitreo-Retinal
There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...
Reduction of postoperative bruising and swelling
This is a review of 27 patients undergoing periocular surgery who postoperatively applied hydrogel pads impregnated with Arnica montana and Ledum palustre (Ocumend, Cearna inc., Chicago). The pads were used continuously for the first two postoperative days, changing them every...Treatment of diabetic macular edema in vitrectomised eyes – comparison of intravitreal dexamethasone implant and posterior subtenon triamcinolone injection
3 April 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Dexamethasone implant, Diabetic macular edema, Pars plana vitrectomy, Posterior subtenon triamcinolone
This retrospective study was aimed to compare intravitreal dexamethasone implant and posterior subtenon triamcinolone injection (PSTA) in the treatment of diabetic macular edema (DME) in vitrectomised eyes. Sixty-four (48.12%) patients who had received PSTA and 69 (51.88%) patients who had...
Considerations in the management of retinal disorders
1 October 2017
| Rod McNeil
|
EYE - Vitreo-Retinal
Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...
Advances and developments in medical retina
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...21st Century retinal laser treatment in the anti-VEGF era
1 June 2017
| John Awad, Prasad Rao
|
EYE - Vitreo-Retinal
In today’s world, macular laser treatment has a vital role in the treatment of diabetic macular oedema (DMO). DMO is one of the most common causes of visual impairment. Despite expensive intravitreal treatment courses of anti-VEGF, many will agree that...